What top creators are saying about Soleno Therapeutics(SLNO)

Biopharmaceutical company targeted by a short-seller report.

2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Soleno Therapeutics in the last 30 days yet.

Top creators covering Soleno Therapeutics (SLNO)

The 1 sources with the most insights about Soleno Therapeutics on Kazuha.

Latest insights about Soleno Therapeutics (SLNO)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Monday, April 6, 2026

Neutral

Mentioned in the context of its acquisition by Neurocrine.

Friday, August 15, 2025

Neutral

A 'battleground' stock with a strong bear case (short report citing safety/IP concerns) and a strong bull case (key doctor support could generate $250M revenue).

Discussed alongside Soleno Therapeutics (SLNO)

Other assets that creators frequently mention in the same content as Soleno Therapeutics.

Frequently asked

Which podcasters and creators cover Soleno Therapeutics (SLNO) the most?

The most active sources covering Soleno Therapeutics (SLNO) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Soleno Therapeutics (SLNO) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Soleno Therapeutics (SLNO) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Soleno Therapeutics (SLNO)?

Creators covering Soleno Therapeutics (SLNO) most frequently also discuss CGEM, NEGG, IONQ, RDDT, PGEN. See the "Discussed alongside" section above for full asset pages.